Goldman Sachs Maintains Calumet Inc (CLMT.US) With Hold Rating, Raises Target Price to $57

Goldman Sachs maintained a Hold rating on Calumet Specialty Products Partners but raised its price target to $57, reflecting an updated positive outlook on the firm's financial prospects.